688580.SH
伟思医疗
SSE · Healthcare · Medical - Devices · CN
CNY 45.68
−5.31%Year over year
Reported trailing growth
- Revenue
- +15.8%
- EBITDA
- —
- EBIT
- +47.4%
- EPS
- +45.5%
- Free cash flow
- -78.2%
- Operating cash flow
- +29.6%
Forward estimates
Based on analyst estimates
- Revenue
- -74.2%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +12.9%
- EBITDA
- +13.9%
- EBIT
- +13.4%
- Net income
- +13.7%
- EPS
- +1.6%
- Free cash flow
- +804.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026